Skip to search boxSkip to navigationSkip to main content

Post-chikungunya chronic inflammatory rheumatism: Follow-up of cases after 1 year of infection in Tolima, Colombia

  • Mónika Patricia Consuegra-Rodríguez
    ,
  • Diana Meliza Hidalgo-Zambrano
    ,
  • Heriberto Vásquez-Serna
    ,
  • Carlos E. Jimenez-Canizales
    ,
  • Esteban Parra-Valencia
    ,
  • Universidad Autónoma de Bucaramanga
    ,
  • Universidad Tecnológica de Pereira
    ,
  • ESE Hospital Santa Bárbara de Venadillo
    ,
  • Ibagué Saludable Research Group
    ,
  • Universidad Surcolombiana
    ,
  • Colombian Collaborative Network of Zika
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 62-68 (7 pages)

Journal (Volume, Issue Number)

Travel Medicine and Infectious Disease (Volume 21)

Publication milestones

  • Published - 01/2018

Publication status

Published - 01/2018

ISSN

1477-8939

Publication IDs

  • Scopus: 85041960935
  • PubMed: 29203304

Abstract

Introduction: Chronic Inflammatory Rheumatism (CIR) is one of the recognized and increasingly reported consequence post-chikungunya infection (pCHIK) in Colombia and Latin America. Methods: Retrospective cohort study of 128 patients with CHIK that persisted with pCHIK-CIR after 59–68 weeks (1.13–1.31 years). This information was evaluated by means of a telephone survey and according to validated criteria (WHO 2015) previously (patients with >12 weeks post-CHIK with ≥1 manifestations [continuous/recurrent]: chronic polyarthralgia [pCHIK-CPA], stiffness and/or joint edema). Results: Of the total CHIK-infected subjects finally included (n = 65), 28 (43.1%) reported pCHIK-CPA; and 38 patients (58.5%) at least one persistent rheumatological symptoms over the last year (pCHIK-CIR); 38.5% of them, morning stiffness, 18.5% joint edema, and 3.1% joint redness. No significant sex differences were found; 60% of patients with pCHIK-CPA aged> 40 years (RR = 3.75; 95%CI 1.47–9.53). The 29.2% of patients required medical attention because of symptoms. Conclusions: Nearly half of patients with CHIK had at least one rheumatologic symptom persistent over a year, and the third of them, pCHIK-CPA. These results are comparable with previous estimates obtained in other cohorts in the country (Risaralda and Sucre) and are consistent with results from other studies in France and India.

Publication metrics

Metrics

Scopus
Citations

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well